Get Fit Bharat

Tag: Myth

HomeMyth

Over the past seven years, Moldova Innovation Technology Park (MITP) has become a cornerstone of Moldova’s economy, contributing an impressive 5% to the national GDP in 2024 and fostering a vibrant technology ecosystem. Launched in 2018, MITP has revolutionized the country’s tech landscape by attracting over 2,130 resident companies, representing industries …

TOKYO, Japan:  Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group Holdings, Inc. (Chairman, President and Group CEO: Shigekazu Takeuchi; Head Office: Minato-ku, Tokyo), and Eisai Co., Ltd. (Representative Corporate Officer and CEO: Haruo Naito; Head Office: Bunkyo-ku, Tokyo; hereinafter "Eisai") announced …

Dr. Narendranadh Meda, one of the city’s leading Vascular, Endovascular & Podiatric Surgeon, has recently added a state-of-the-art Esaote’s O-Scan MRI machine from Esaote to his hospital, further elevating the standard of care provided to patients in Hyderabad and surrounding regions. The acquisition of this advanced diagnostic technology is expected to significantly improve the …

CHICAGO, United States:  Hyatt Hotels Corporation (the “Company” or “Hyatt”) (NYSE: H) today disclosed it has executed an exclusivity agreement with Playa Hotels & Resorts N.V. (“Playa”) (NASDAQ: PLYA) under which Playa has agreed to negotiate exclusively with Hyatt regarding potential strategic alternatives, which may include the acquisition of Playa by …

Relais Group PlcStock Exchange Release 23 December 2024 at 1:20 p.m. EET  The Board of Directors of Relais Group Plc has decided to cancel a total of 71,785 Relais Group shares i.e., approximately 0.40 percent of the total number of the company's shares. 71,735 treasury shares to be cancelled were …

San Mateo, Calif., United States:  BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., announced it will change its Nasdaq ticker symbol to “ONC” on January 2, 2025, reflecting its long-standing commitment to delivering innovative oncology medicines globally. …